Berkshire Hathaway Acquires OxyChem for $9.7 Billion, Signaling Potential Leadership Shift
Berkshire Hathaway has announced the acquisition of Occidental Petroleum's chemical division, OxyChem, for $9.70 billion. The deal, expected to close in Q4, was led by Vice Chair Greg Abel, potentially signaling a leadership transition. OxyChem produces chlorine, vinyl chloride, and calcium chloride. Occidental plans to use $6.50 billion of the proceeds to reduce debt. Berkshire already holds over 28% of Occidental's stock, warrants, and $8.50 billion in preferred shares. The acquisition represents less than 3% of Berkshire's $344.00 billion cash reserves.

*this image is generated using AI for illustrative purposes only.
Berkshire Hathaway, the conglomerate led by legendary investor Warren Buffett, has made a significant move in the chemical industry by announcing the acquisition of Occidental Petroleum's chemical division, OxyChem, for $9.70 billion. This strategic purchase not only expands Berkshire's portfolio but also hints at a potential leadership transition within the company.
Deal Highlights
- Berkshire Hathaway to acquire OxyChem for $9.70 billion
- Transaction expected to close in the fourth quarter
- Acquisition represents less than 3% of Berkshire's $344.00 billion cash reserves
Potential Leadership Transition
In an interesting twist, the announcement was spearheaded by Vice Chair Greg Abel, rather than Warren Buffett himself. This move is particularly noteworthy as Abel is set to assume the role of CEO in January, potentially signaling a gradual shift in leadership dynamics at Berkshire Hathaway.
OxyChem's Business Profile
OxyChem, the chemical division of Occidental Petroleum, is a significant player in the chemical industry with a diverse product portfolio:
- Chlorine production for water treatment
- Vinyl chloride manufacturing for plastics
- Calcium chloride production for road treatment
The division's financial performance has seen some fluctuation, with pretax earnings of $213.00 million in the second quarter, down from nearly $300.00 million in the previous year.
Strategic Implications for Occidental Petroleum
For Occidental Petroleum, this divestiture aligns with its broader financial strategy:
- Plans to use $6.50 billion of the proceeds to reduce debt below $15.00 billion
- Supports Occidental's recent CrownRock acquisition strategy
Berkshire's Existing Stake in Occidental
This acquisition further solidifies Berkshire Hathaway's relationship with Occidental Petroleum. Prior to this deal, Berkshire already held:
- More than 28% of Occidental's stock
- Warrants for additional shares
- $8.50 billion in preferred shares
The OxyChem acquisition represents a deepening of Berkshire's involvement in Occidental's operations and the chemical sector as a whole.
Financial Impact
While the $9.70 billion price tag is substantial, it's important to note that this acquisition represents less than 3% of Berkshire Hathaway's impressive $344.00 billion cash reserves. This demonstrates the company's continued ability to make large-scale investments while maintaining a strong financial position.
As the deal moves towards its expected closure in the fourth quarter, market observers will be keenly watching for any further indications of leadership transition at Berkshire Hathaway and the potential impact of this acquisition on both companies' future strategies and performance.